Owens & Minor Stock Forecast, Price & News

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Owens & Minor in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Owens & Minor stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMI, but not buy additional shares or sell existing shares.
View analyst ratings for Owens & Minor or view top-rated stocks.

Wall Street analysts have given Owens & Minor a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Owens & Minor wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Owens & Minor saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 5,350,000 shares, a decrease of 17.3% from the May 31st total of 6,470,000 shares. Based on an average daily trading volume, of 1,190,000 shares, the days-to-cover ratio is presently 4.5 days. Currently, 7.4% of the shares of the company are sold short.
View Owens & Minor's Short Interest.

Owens & Minor is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021.
View our earnings forecast for Owens & Minor.

Owens & Minor, Inc. (NYSE:OMI) posted its quarterly earnings results on Tuesday, August, 3rd. The company reported $1.06 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.99 by $0.07. The company had revenue of $2.49 billion for the quarter, compared to the consensus estimate of $2.48 billion. Owens & Minor had a net margin of 1.28% and a trailing twelve-month return on equity of 43.12%. Owens & Minor's quarterly revenue was up 37.7% on a year-over-year basis. During the same period in the prior year, the business earned $0.20 earnings per share.
View Owens & Minor's earnings history.

Owens & Minor's stock was trading at $4.48 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OMI stock has increased by 854.5% and is now trading at $42.76.
View which stocks have been most impacted by COVID-19.

Owens & Minor declared a quarterly dividend on Friday, July 30th. Shareholders of record on Wednesday, September 15th will be given a dividend of $0.002 per share on Thursday, September 30th. This represents a $0.01 dividend on an annualized basis and a yield of 0.02%. The ex-dividend date of this dividend is Tuesday, September 14th.
View Owens & Minor's dividend history.

Owens & Minor pays an annual dividend of $0.01 per share and currently has a dividend yield of 0.02%. Owens & Minor does not yet have a strong track record of dividend growth. The dividend payout ratio of Owens & Minor is 0.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Owens & Minor will have a dividend payout ratio of 0.29% next year. This indicates that Owens & Minor will be able to sustain or increase its dividend.
View Owens & Minor's dividend history.

Owens & Minor updated its FY 2021 earnings guidance on Tuesday, August, 3rd. The company provided earnings per share (EPS) guidance of $3.750-$4.250 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.970. The company issued revenue guidance of -.

7 brokers have issued 12-month target prices for Owens & Minor's shares. Their forecasts range from $22.00 to $55.00. On average, they anticipate Owens & Minor's stock price to reach $37.29 in the next twelve months. This suggests that the stock has a possible downside of 12.8%.
View analysts' price targets for Owens & Minor or view top-rated stocks among Wall Street analysts.

36 employees have rated Owens & Minor CEO Ed Pesicka on Glassdoor.com. Ed Pesicka has an approval rating of 65% among Owens & Minor's employees.

Some companies that are related to Owens & Minor include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Henry Schein (HSIC) and Patterson Companies (PDCO).
View all of OMI's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Owens & Minor investors own include Advanced Micro Devices (AMD), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Micron Technology (MU), NVIDIA (NVDA), Applied Materials (AMAT), Enterprise Products Partners (EPD), Johnson & Johnson (JNJ) and Cisco Systems (CSCO).

Owens & Minor trades on the New York Stock Exchange (NYSE) under the ticker symbol "OMI."

Owens & Minor's stock is owned by many different retail and institutional investors. Top institutional shareholders include Ceredex Value Advisors LLC (0.72%), MESIROW FINANCIAL INVESTMENT MANAGEMENT Equity & Fixed Income (0.27%), Alliancebernstein L.P. (0.24%), Hillsdale Investment Management Inc. (0.20%), Cozad Asset Management Inc. (0.11%) and New York State Common Retirement Fund (0.09%). Company insiders that own Owens & Minor stock include Christopher M Lowery, Jonathan A Leon, Lawrence Lacerte, Mark P Zacur, Michael Wayne Lowry, Robert J Henkel, Robert Weideman and Shana Carol Neal.
View institutional ownership trends for Owens & Minor.

OMI stock was sold by a variety of institutional investors in the last quarter, including Heritage Wealth Advisors, Lbmc Investment Advisors LLC, Cozad Asset Management Inc., Victory Capital Management Inc., Cutler Group LP, Hillsdale Investment Management Inc., Dupont Capital Management Corp, and USA Financial Portformulas Corp. Company insiders that have sold Owens & Minor company stock in the last year include Christopher M Lowery, Jonathan A Leon, Lawrence Lacerte, Mark P Zacur, Michael Wayne Lowry, Robert Weideman, and Shana Carol Neal.
View insider buying and selling activity for Owens & Minor or view top insider-selling stocks.

OMI stock was bought by a variety of institutional investors in the last quarter, including Ceredex Value Advisors LLC, MESIROW FINANCIAL INVESTMENT MANAGEMENT Equity & Fixed Income, Alliancebernstein L.P., Clear Creek Financial Management LLC, Jackson Creek Investment Advisors LLC, Handelsbanken Fonder AB, Advisor Group Holdings Inc., and State of Alaska Department of Revenue.
View insider buying and selling activity for Owens & Minor or or view top insider-buying stocks.

Shares of OMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OMI stock can currently be purchased for approximately $42.76.

Owens & Minor has a market capitalization of $3.21 billion and generates $8.48 billion in revenue each year. The company earns $29.87 million in net income (profit) each year or $2.26 on an earnings per share basis.

Owens & Minor employs 18,800 workers across the globe.

The following companies are subsidiares of Owens & Minor: 500 Expressway Drive South LLC, 5nq, AVID Medical Inc., Access Diabetic Supply, Access Diabetic Supply L.L.C., Access Respiratory Supply Inc, Arabian Medical Products Manufacturing Company, ArcRoyal, ArcRoyal Holdings Unlimited Company, ArcRoyal Unlimited Company, Barista Acquisition I LLC, Barista Acquisition II LLC, Byram Healthcare Centers, Byram Healthcare Centers Inc., Byram Holdings I Inc., Clinical Care Services L.L.C., Cyrus Medical Systems, Diabetes Specialty Center L.L.C., Fusion 5 Inc., Halyard Health - S&IP, Halyard Malaysia SND BHD, Halyard North Carolina LLC, HealthCare Logistics Services, Key Diabetes Supply Co., La Ada de Acuna S. de R.L. de C.V., MAI Acquisition Corp., MIRA Medsource (Malaysia) SDN. BHD., McKesson's Acute-Care Medical, Medegen Newco LLC, Medical Action Industries, Medical Action Industries Inc., Medical Supply Group Inc., Mira MEDsource (Shanghai) Co. LTD, Mira MEDsource Holding Company Limited, Movianto, Nalvest Limited, O and M Halyard South Africa Pty Ltd, O&M Brasil Consultoria Ltda, O&M Byram Holdings GP, O&M Funding LLC, O&M Halyard Australia PTY LTD, O&M Halyard Belgium, O&M Halyard Canada Inc., O&M Halyard France, O&M Halyard Germany GmbH, O&M Halyard Health India Private Limited, O&M Halyard Honduras S.A. de C.V., O&M Halyard Inc., O&M Halyard International Unlimited Company, O&M Halyard Ireland Limited, O&M Halyard Japan GK, O&M Halyard Mexico S. de R.L. de C.V., O&M Halyard Netherlands B.V., O&M Halyard Singapore PTE Ltd, O&M Halyard UK Limited, O&M Healthcare Italia S.R.L., O&M International Healthcare C.V., O&M Worldwide LLC, OMSolutions International Inc., Owens & Minor Canada Inc., Owens & Minor Distribution Inc., Owens & Minor Global Resources LLC, Owens & Minor Global Services Unlimited Company, Owens & Minor Healthcare Supply Inc., Owens & Minor Inc., Owens & Minor Inc. Executive Deferred Compensation Trust, Owens & Minor International Logistics Inc., Owens & Minor International Unlimited Company, Owens & Minor Ireland Unlimited Company, Owens & Minor Jersey Holdings Limited, Owens & Minor Jersey Unlimited, Owens & Minor Medical Inc., Safeskin Medical & Scientific (Thailand) Ltd., Stuart Medical, and The Burrows Company.

Owens & Minor was founded in 1882.

The official website for Owens & Minor is www.owens-minor.com.

Owens & Minor is headquartered at 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261.

Owens & Minor's mailing address is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. The company can be reached via phone at (804) 723-7000 or via email at [email protected]